STING1 and neoplasm: To tackle the unwanted inhibition of productive immune responses to such cells, the development of antagonists for STING-suppressive pathways including caspase-9 or caspase 3/7 inhibitors or by interfering with the rapid regulatory STING turnover, might circumvent immunologically silenced apoptosis and might enhance anti-tumor responses [229,230].